- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07943429
Strategies to Improve RTS,S-4 Uptake and Integration With Other Child Health Services
Investigating Approaches to Increase the Uptake of Malaria Vaccine and Other Childhood Health Interventions in Western Kenya: a Feasibility Study
This study will identify and evaluate innovative approaches to leverage malaria vaccine visits as opportunities to enhance the delivery of other child health services in Rarieda sub-county, Siaya County, Kenya where RTS,S became part of their routine childhood immunization programs in 2019. Using a human-centred design approach, the implementation research will be conducted in two phases.
Phase 1 (Diagnose and Design) will consist of formative research to understand current practices, barriers, and facilitators for childhood health and malaria interventions using the WHO's behavioural and social drivers' framework for immunization. Having identified the barriers and facilitators to uptake, the investigators will prioritize drivers and develop innovations for implementation in collaboration with communities, healthcare workers and managers.
Phase 2 (Implement and Evaluate) will focus on implementing and evaluating the innovations developed in Phase 1. Using the RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) Framework, the study will assess the extent to which the interventions reach the target population, effectiveness of leveraging the malaria vaccine to increase uptake of other child health interventions, the extent of adoption by key stakeholders, and the fidelity and quality of implementation. The investigators will also explore cost and long-term sustainability.
The study will employ a mixed-methods approach, leveraging quantitative and qualitative data from health facility records, surveys, interviews, and observations.
The investigators will generate evidence on leveraging malaria vaccine visits and activities through: (i) innovative implementation strategies designed to maximize immunizations, child health interventions, and malaria prevention uptake; (ii) community engagement as an approach to optimize vaccine uptake and coverage; (iii) detailed qualitative data on the acceptability, perceptions, and barriers to uptake of vaccines and child health interventions; (iv) approaches to ensure access for zero-dose, under-vaccinated and underserved populations.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
- Comportamentale: Provide ITNs at RTS,S-4 visit
- Comportamentale: Community Health Promoters identify and refer under-vaccinated children to health facilities
- Comportamentale: Enhanced defaulter tracing with use of mobile technology
- Comportamentale: Strengthening immunization systems, health services, and interdepartmental collaboration
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
-
Siaya, Kenya
- Ong'ielo Health Centre
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
-
Primary caregivers of children eligible for malaria vaccination:
- Inclusion criteria: Primary caregivers (age 18 years or older) of children who are eligible for or have received at least one dose of malaria vaccine
- Exclusion criteria: Caregivers who are not the primary decision-makers for the child's healthcare or who have resided in the study area for less than 3 months
-
Healthcare workers involved in immunization services:
- Inclusion criteria: Clinical officers, nurses, or other healthcare staff directly involved in providing immunization services at the selected health facilities for at least 3 months
- Exclusion criteria: Healthcare workers not involved in immunization service delivery or who have worked at the facility for less than 3 months
-
Community health promoters (CHPs):
- Inclusion criteria: CHPs working in the catchment areas of selected health facilities for at least 6 months
- Exclusion criteria: CHPs who have not been active in the past 3 months
-
Community members and leaders:
- Inclusion criteria: community members and leaders willing to share their views on malaria vaccine barriers and facilitators, and approaches to improve uptake.
- Exclusion criteria: Community members not willing to participate in the study
-
Health facility managers and sub-county/county/national health officials:
- Inclusion criteria: Health facility in-charges, sub-county or county EPI coordinators, and other relevant health officials overseeing immunization services across MoH hierarchy
- Exclusion criteria: Officials who have been in their current position for less than 3 months
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: ITN - Provision of ITNs at RTS,S-4 visit
Leverage malaria vaccine to improve ITN access and use by providing ITNs at the 4th malaria dose visit, as well as vitamin A, deworming, MR2 and other missing vaccines |
- At RTS,S-4 visit, health workers (HW) screen children for missing vaccinations and health services - HW provide catch-up vaccinations and services |
|
Sperimentale: CHP - CHP identify and refer under-vaccinated children to health facility
Using malaria vaccine as an entry point, CHPs systematically identified under-vaccinated children during routine household visits and referred them to health facilities (HF), integrating immunization tracking into routine community activities. |
|
|
Sperimentale: SMS - Enhanced defaulter tracing with use of mobile technology
Facility-community linkages were strengthened through CHP engagement and mobile phone-based reminders, including SMS notifications and defaulter tracing |
|
|
Sperimentale: SS - Strengthening immunization systems, health services, and interdepartmental collaboration
Multi-component intervention: 1) strengthening immunizations and health services through interdepartmental collaboration; 2) improving vaccine visit awareness, preparedness, and defaulter tracing; and 3) targeted monthly community outreaches, with CHPs mobilizing caregivers of children due or overdue for vaccination. |
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Reach
Lasso di tempo: Three months
|
Vaccine coverage (%) in target populations and characteristics of vaccinated populations reached through study interventions |
Three months
|
|
Effectiveness
Lasso di tempo: Three months
|
Percentage increase in primary (dose 1-3) and booster (4th) doses post-interventions in age-eligible children |
Three months
|
|
Adoption
Lasso di tempo: Three months
|
Proportion of RTS,S vaccines provided concurrently with other vaccines/services. |
Three months
|
|
Implementation
Lasso di tempo: Three months
|
Perceived feasibility of interventions by health workers, caregivers, and community. A semi-structured interview guide will be used to assess implementation experiences. |
Three months
|
|
Maintenance
Lasso di tempo: Three months
|
Drivers of maintenance of interventions. A semi-structured interview guide will be used to elicit what it would take to continue implementing interventions beyond the study period. |
Three months
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Simon Kariuki, PhD, Kenya Medical Research Institute
- Investigatore principale: Nelli Westercamp, PhD, Centres for Disease Control and Prevention
Pubblicazioni e link utili
Pubblicazioni generali
- UNICEF Office of Innovation. Human-Centered Design. UNICEF.
- Malaria vaccines (RTS,S and R21). WHO. https://www.who.int/news-room/questions-and-answers/item/q-a-on-rts-s-malaria-vaccine.
- Kenya Medical Research Institute, Centers for Disease Control and Prevention. Kenya MVPE Feasibility Evaluation: Results of the baseline household survey. Published November 2020.
- President's Malaria Initiative. Kenya PMI Fact Sheet In-Country FY 2023. PMI.gov. https://www.pmi.gov/wp-content/uploads/2023/04/Kenya_PMI-Fact-Sheet-InCountry_FY2023_CP_checked.pdf
- Boselli G, Yajima A, Aratchige PE, Feldon KE, Xeuatvongsa A, Phounphenghak K, Sihakhang K, Chitsavang C, Phengkeo S, Gabrielli AF, Politi C, Montresor A. Integration of deworming into an existing immunisation and vitamin A supplementation campaign is a highly effective approach to maximise health benefits with minimal cost in Lao PDR. Int Health. 2011 Dec;3(4):240-5. doi: 10.1016/j.inhe.2011.08.002.
- Wallace A, Dietz V, Cairns KL. Integration of immunization services with other health interventions in the developing world: what works and why? Systematic literature review. Trop Med Int Health. 2009 Jan;14(1):11-9. doi: 10.1111/j.1365-3156.2008.02196.x. Epub 2008 Nov 12.
- Ching P, Birmingham M, Goodman T, Sutter R, Loevinsohn B. Childhood mortality impact and costs of integrating vitamin A supplementation into immunization campaigns. Am J Public Health. 2000 Oct;90(10):1526-9. doi: 10.2105/ajph.90.10.1526.
- Oresanya O, Phillips A, Okereke E, Ahmadu A, Ibinaiye T, Marasciulo M, Ward C, Adesoro O, Mohammed R, Nikau J, Isokpunwu CO, Inname MA, Counihan H, Baker K, Maxwell K, Smith H. Co-implementing vitamin A supplementation with seasonal malaria chemoprevention in Sokoto State, Nigeria: a feasibility and acceptability study. BMC Health Serv Res. 2022 Jul 5;22(1):871. doi: 10.1186/s12913-022-08264-z.
- National Malaria Control Programme. Towards Malaria-Free Kenya: Kenya Malaria Strategy 2019-2023. Nairobi, Kenya: Ministry of Health; 2019.
- Elnour Z, Grethe H, Siddig K, Munga S. Malaria control and elimination in Kenya: economy-wide benefits and regional disparities. Malar J. 2023 Apr 7;22(1):117. doi: 10.1186/s12936-023-04505-6.
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- KEMRI/SERU/CGHR/537/5206
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Only aggregated data is required for reports and manuscripts.
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .